LISA DAVENPORT: Open Payments
NPI 1861918344 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 10 payments from 6 companies in 2025. Trend: 2023 $118 · 2024 $366 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Tris Pharma Inc | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, AUSTEDO XR, Onyda XR, COBENFY, INVEGA SUSTENNA, Qelbree.
Industry payments across TX — which companies pay providers there.
